384 related articles for article (PubMed ID: 25545289)
61. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
62. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
Zhang HZ; Ye X; Sun ZG
Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338
[TBL] [Abstract][Full Text] [Related]
63. Flow cytometric cerebrospinal fluid analysis in children.
Häusler M; Sellhaus B; Schweizer K; Ramaekers VT; Opladen T; Kleines M
Pathol Res Pract; 2003; 199(10):667-75. PubMed ID: 14666969
[TBL] [Abstract][Full Text] [Related]
64. Quantitative evaluation of Cerebrospinal fluid (CSF) samples in pediatric patients with low-risk ALL using multiparameter flow cytometry.
Torkashvand M; Goudarzipour K; Allahbakhshian Farsani M; Amiri V; Mohammadi MH; Hashemieh M; Eshghi P
Int J Lab Hematol; 2020 Aug; 42(4):e152-e154. PubMed ID: 32329964
[No Abstract] [Full Text] [Related]
65. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M;
Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378
[TBL] [Abstract][Full Text] [Related]
66. The expense of sending cerebrospinal fluid for analysis on all lumbar punctures in pediatric acute lymphoblastic leukemia patients.
Wilson J; Liebman MF; Johnston DL
Pediatr Blood Cancer; 2022 Aug; 69(8):e29585. PubMed ID: 35147285
[TBL] [Abstract][Full Text] [Related]
67. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma?
Dunphy CH
Cytometry; 2000 Oct; 42(5):296-306. PubMed ID: 11025488
[TBL] [Abstract][Full Text] [Related]
68. Soluble L-selectin increases in the cerebrospinal fluid prior to meningeal involvement in children with acute lymphoblastic leukemia.
Dagdemir A; Ertem U; Duru F; Kirazli S
Leuk Lymphoma; 1998 Jan; 28(3-4):391-8. PubMed ID: 9517511
[TBL] [Abstract][Full Text] [Related]
69. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia.
Raje NS; Vaidya SJ; Kapoor G; Pai SK; Nair CN; Kurkure PA; Magrath IT; Advani SH
Indian Pediatr; 1996 Jul; 33(7):556-60. PubMed ID: 8979564
[TBL] [Abstract][Full Text] [Related]
70. The role of magnetic resonance imaging in the diagnosis of central nervous system involvement in children with acute lymphoblastic leukemia.
Lauer M; Kernen E; Schwabe D; Lehrnbecher T; Porto L
Pediatr Blood Cancer; 2020 Oct; 67(10):e28294. PubMed ID: 32743972
[TBL] [Abstract][Full Text] [Related]
71. Cerebrospinal fluid involvement in mantle cell lymphoma.
Valdez R; Kroft SH; Ross CW; Schnitzer B; Singleton TP; Peterson LC; Finn WG
Mod Pathol; 2002 Oct; 15(10):1073-9. PubMed ID: 12379754
[TBL] [Abstract][Full Text] [Related]
72. TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse.
Jaime-Pérez JC; Gamboa-Alonso CM; Jiménez-Castillo RA; López-Silva LJ; Pinzón-Uresti MA; Gómez-De León A; Gómez-Almaguer D
Blood Cells Mol Dis; 2017 Mar; 63():27-31. PubMed ID: 28061377
[TBL] [Abstract][Full Text] [Related]
73. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
74. Monocytopenia as a diagnostic clue to pediatric B-lymphoblastic leukemia with rare circulating blasts.
Park SI; Rogers BB
Pediatr Dev Pathol; 2014; 17(2):112-7. PubMed ID: 24804826
[TBL] [Abstract][Full Text] [Related]
75. Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Garcia KA; Cherian S; Stevenson PA; Martino CH; Shustov AR; Becker PS; Percival MM; Oehler VG; Halpern AB; Walter RB; Orozco JJ; Keel SB; Estey EH; Cassaday RD
Cancer; 2022 Apr; 128(7):1411-1417. PubMed ID: 34931301
[TBL] [Abstract][Full Text] [Related]
76. [Cerebrospinal fluid studies in acute lymphoblastic leukemia and lymphosarcomas in children].
Bondarenko LV
Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):56-7. PubMed ID: 8154221
[TBL] [Abstract][Full Text] [Related]
77. Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry.
Tani E; Costa I; Svedmyr E; Skoog L
Diagn Cytopathol; 1995 Feb; 12(1):14-22. PubMed ID: 7789240
[TBL] [Abstract][Full Text] [Related]
78. Immunophenotypic characteristics of cerebrospinal fluid cells in children with acute lymphoblastic leukemia at diagnosis.
Homans AC; Barker BE; Forman EN; Cornell CJ; Dickerman JD; Truman JT
Blood; 1990 Nov; 76(9):1807-11. PubMed ID: 2171701
[TBL] [Abstract][Full Text] [Related]
79. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
Lossos IS; Breuer R; Intrator O; Lossos A
Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
[TBL] [Abstract][Full Text] [Related]
80. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
